News and Views


Nature Immunology 8, 477 - 478 (2007)
doi:10.1038/ni0507-477

Smads keep TABs on inflammation

Rashu B Seth1 & Zhijian J Chen1

  1. Rashu B. Seth and Zhijian J. Chen are with the Howard Hughes Medical Institute and Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA. e-mail: zhijian.chen@utsouthwestern.edu


Smad7 controls inflammation by negatively regulating activation of the transcription factor NF-kappaB. New work shows that Smad7 inhibits NF-kappaB by binding to the regulatory proteins TAB2 and TAB3, thereby blocking association of the E3 ubiquitin ligase TRAF2 with the kinase TAK1.

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Signal transduction Aspirin, ubiquitin and cancer

Nature News and Views (14 Aug 2003)

E2 enzymes: expanding the 'ubi-verse' of immune signaling

Nature Immunology News and Views (01 Sep 2006)

See all 7 matches for News And Views

Extra navigation

Subscribe to Nature Immunology

Subscribe

Open Innovation Challenges

naturejobs

ADVERTISEMENT